BDBM795216 N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)phenylamino) pyrimidin-4-yl)benzamide::US12570614, Compound 36

SMILES N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCC(O)CC4)cc3)n2)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 795216   

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795216BDBM795216(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/20/2026
Entry Details US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795216BDBM795216(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/20/2026
Entry Details US Patent